Jim Cramer advises holding Marvell Technology, is uncertain about Palantir, dislikes Recursion Pharmaceuticals, and sees potential in IonQ.
Jim Cramer, "Mad Money" host, advises holding onto Marvell Technology in a lightning round where he quickly answers callers' stock questions. He is unsure about Palantir due to its unclear nature, but mentions that if the company can reinvent itself, it could be worthwhile. He dislikes desperation in Recursion Pharmaceuticals, and IonQ could be worth investing in if the company made a profit.
June 28, 2024
3 Articles